文献
J-GLOBAL ID:201902234934388258
整理番号:19A0176915
インフルエンザPB2の新規経口バイオアベイラビリティβ-アミノ酸アザインドール阻害剤の発見【JST・京大機械翻訳】
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2
著者 (25件):
Farmer Luc J.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Clark Michael P.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Boyd Michael J.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Perola Emanuele
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Jones Steven M.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Tsai Alice
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Jacobs Marc D.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Bandarage Upul K.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Ledeboer Mark W.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Wang Tiansheng
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Deng Hongbo
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Ledford Brian
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Gu Wenxin
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Duffy John P.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Bethiel Randy S.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Shannon Dean
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Byrn Randal A.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Leeman Joshua R.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Rijnbrand Rene
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Bennett Hamilton B.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
O’Brien Colleen
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Memmott Christine
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Nti-Addae Kwame
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Bennani Youssef L.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
,
Charifson Paul S.
(Vertex Pharmaceuticals Inc., Massachusetts, United States)
資料名:
ACS Medicinal Chemistry Letters
(ACS Medicinal Chemistry Letters)
巻:
8
号:
2
ページ:
256-260
発行年:
2017年
JST資料番号:
W5043A
ISSN:
1948-5875
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)